Aug
16
2018

Regenerative Medicine: Finding Ways for the Body to Heal Itself

William Blair

One of the most exciting areas in healthcare today is regenerative medicine. This simple term encompasses a rapidly expanding revolution in medical research, which in its application by physicians is allowing the body to heal itself in ways never before seen.

Aug
13
2018

New Drugs so Pricey They Need New Payment Plans

Politico Prescription Pulse

So far, regenerative medicine and other advanced therapies — including CAR-T and stem cell therapies — haven’t met market expectations because of difficulties determining their value, according to a recent analysis from the ARM Foundation for Cell and Gene Medicine. Innovative payment models have helped overcome payer uncertainty about high upfront costs, according to the foundation’s analysis.

Aug
09
2018

Investors Are Pouring Money into Gene and Cell Therapy

STAT: The Readout

You probably already knew that there’s a ton of activity and investment in the cell and gene therapy space. But just how much? A new report takes a stab at quantifying the excitement.

Aug
09
2018

ARM Releases Second-Quarter Report on Regenerative Medicines Sector

BioPharm International

The Alliance for Regenerative Medicine’s (ARM) report highlights major trends and metrics from the 2018 second quarter in the regenerative medicines sector.

Aug
06
2018

A ‘landscape analysis’ of reimbursement practices for cellular and genetic therapies

Pharmaceutical Commerce

In either case, the Alliance for Regenerative Medicine’s Research Foundation (ARM Foundation) has issued a “landscape analysis” of current evaluation and reimbursement structures for cellular and genetic therapies just getting onto the market now. This landscape analysis will be followed by a stakeholder panel, possibly meeting in the fall, and a white paper or other position statement after that, according to Morrie Ruffin, executive director of the ARM Foundation. The project was announced earlier this year, and IQVIA is onboard as a contractor.

Jul
27
2018

Group Working To Close 'Standards Gaps' For Cell And Gene Therapies

Pink Sheet Pharma Intelligence

A standards coordination group has identified and is working to fill gaps in standards for cell and gene therapies in a congressionally mandated effort to strengthen regulatory predictability for manufacturers working to develop and launch commercial cell and gene therapies.